EP300 improves endothelial injury and mitochondrial dysfunction in coronary artery disease by regulating histone acetylation of SOCS1 promoter via inhibiting JAK/STAT pathway
Wenbo Xue, Liuping Deng
Topics & Concepts
Suppressor of cytokine signaling 1Cancer researchEndothelial dysfunctionEndotheliumBiologyJAK-STAT signaling pathwayEndothelial stem cellMedicineCell biologyInternal medicineSignal transductionEndocrinologyBiochemistryTyrosine kinaseIn vitroCancerSuppressorCytokine Signaling Pathways and InteractionsAtherosclerosis and Cardiovascular DiseasesNuclear Receptors and Signaling